In vivo administration of a monoclonal antibody against the type I IL-1 receptor inhibits the ability of mice to eliminate <i>Mycobacterium paratuberculosis</i>

K B Kenefick, J L Adams, Howard Steinberg, Charles J. Czuprynski

Journal of Leukocyte Biology · 1994 · 11 citations · 0 references

Concepts

Abstract

The purpose of this study was to determine the influence of endogenous interleukin-1 (IL-1) on resistance to paratuberculosis infection in experimentally infected gnotobiotic mice. Following a 6-month treatment with prednisolone to facilitate bacillary multiplication, control mice substantially reduced the numbers of M. paratuberculosis in the liver and ileum. In contrast, mice injected with a monoclonal antibody against the type I IL-1 receptor failed to reduce the numbers of M. paratuberculosis in the liver and ileum and exhibited more liver granulomas, which contained numerous acid-fast bacilli. These results indicate a significant role for endogenous IL-1 in host defense against experimental M. paratuberculosis infection in mice.